EndoChoice’s Fuse System Cuts Down on Missed Colon Adenomas, Study Shows

EndoChoice released research backing the FDA-approved Fuse system as a more accurate method for preventing colorectal cancer and reducing the number of adenomas missed by colonoscopists.

Advertisement

EndoChoice revealed its study at the Digestive Disease Week meeting this past May.

The Fuse system uses three small cameras at the tip of a flexible endoscope. The three cameras are designed to give physicians twice as much visibility as a traditional endoscope.

A trial of 185 patients found 42 percent of adenomas were missed by traditional colonscopes and just 8 percent were missed by the Fuse.

More Articles on Gastroenterology:
Gary La Pelusa Association Names Dr. Anaaka Prakash ‘Man of the Year’
Vice & Associates Clinical Research Expands Gastroenterology Suite, Team Members
Drs. Rayees Nizam, Thomas Lee Join Associated Gastroenterologists of Central New York

Advertisement

Next Up in GI & Endoscopy

  • Gastroenterologists are raising concerns about the CMS’ finalized payment policies, according to a joint statement from the American College of…

  • As gastroenterology evolves, leaders are reimagining how to deliver comprehensive, patient-centered care.  Dinesh Madhok, MD, CEO of Jacksonville, Fla.-based Borland…

Advertisement

Comments are closed.